ASPHALION
Sergio Veiga is a seasoned scientific and regulatory affairs professional currently serving as a Senior Officer at ASPHALION since November 2021. With a strong background in research and development management as R&D Manager at Biocross S.L. and extensive experience as a Senior Study Director at CRO Research, Sergio specializes in toxicology, efficacy, and pharmacokinetic pre-clinical studies, particularly in inhalation toxicology. Academic contributions include roles as Associate Professor at Universidad Complutense de Madrid and postdoctoral researcher at both UCSF and Instituto Cajal, which involved securing fellowship awards and publishing extensively in peer-reviewed journals. Sergio holds a Ph.D. in Neurobiology and a Bachelor’s Degree in Biology from Universidad Complutense de Madrid.
This person is not in any teams
ASPHALION
ASPHALION is an International Scientific and Regulatory Affairs consultancy firm based in Barcelona and Munich.They offer comprehensive services for Drug Development and Regulatory Affairs to Pharma, Biotech and Medical Devices companies.Since 2000, we have consistently grown and now have over 70 professional consultants with backgrounds inLife sciences (Pharmacy, Chemistry, Biology, Biochemistry, Biotechnology, Medicine and Veterinary Medicine). Their consultants are experts in their field and are in direct contact with EU agencies (EMA and NCAs) for the development and implementation of new regulatory standards.Asphalion provides a global range of services, for global clients. Their services range from early development, throughout the registration, until marketing and post-commercialization phases of your product.